0.40% 0.0359

Leverage Shares 2 X Long Grab Daily Etf (GRAG)

개요 뉴스 가격 이력 토론 예측

Relative Volume:

Leverage Shares 2 X Long Grab Daily Etf Stock (GRAG) Company Profile

Leverage Shares 2 X Long Grab Daily Etf

Financial (5801)

최신 SEC 제출 서류

GRAG's Discussions on Twitter

Compare GRAG vs VTI, SPY, IVV, VB, QQQ

주식	가격	시가총액
GRAG Leverage Shares 2 X Long Grab Daily Etf	9.02	0
VTI Vanguard Total Stock Market Etf	350.21	417.53B
SPY Spdr S P 500 Etf Trust	708.72	372.57B
IVV Ishares Core S P 500 Etf	712.09	253.41B
VB Vanguard Small Cap Etf	286.16	160.59B
QQQ Invesco Qqq Trust Series 1	646.79	124.43B

Leverage Shares 2 X Long Grab Daily Etf 주식(GRAG)의 최신 뉴스

Leverage Shares 2 X Long Grab Daily Etf (GRAG) 재무 분석

Leverage Shares 2 X Long Grab Daily Etf (GRAG)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.

Leverage Shares 2 X Long Grab Daily Etf (GRAG)

Leverage Shares 2 X Long Grab Daily Etf Stock (GRAG) Company Profile

Compare GRAG vs VTI, SPY, IVV, VB, QQQ

Leverage Shares 2 X Long Grab Daily Etf 주식(GRAG)의 최신 뉴스

Conquest of Prague Online Stage 2026: Sashi Esport vs. Sinners Map 1 - Coinbase

Northern Colorado vs St. Thomas (MN) - Coinbase

Charlotte at Orlando: Spread - Coinbase

Traffic and trepidation in the Persian Gulf could keep gasoline prices from dropping quickly - Barchart

West Play-In: Golden State at Phoenix - Coinbase

A Tectonic Shift in AI Is Underway and AMD Stock Is No Longer a ‘Discount’ Competitor to Nvidia. It’s a Bet on the Future. - Barchart

Grab This Brazen Bullish Opportunity in Hard-Hit American Airlines Stock Now - Barchart

NSCLC Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | AbbVie, AstraZeneca and Daiichi Sankyo, Shanghai Henlius Biotech, Moderna Therapeutics/ Merck, BeyondSpring, Cullinan - Barchart

Critical Limb Ischemia Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | Baxter, Ixaka, Hemostemix Inc., Caladrius Biosciences, Vericel Corporation, Helixmith, Lifecells, LLC - Barchart

Chronic Wounds Market: Accelerating Growth and Pipeline Impact by 2034 – DelveInsight | Paracrine, Inc, Oneness Biotech, MediWound, PolarityTE - Barchart

Is This Dividend King With a 63-Year Dividend Streak A Buy Before April 14? - Barchart

Axonex Intelligence's AI Robotics Series Makes a Splash at InnoEX - Barchart

An underwater bus in Havana becomes the ride that matters during Cuba's fuel crisis - Barchart.com

GRAG Options Volatility — NASDAQ:GRAG - TradingView

GRAG Options Chain — NASDAQ:GRAG - TradingView

D-Wave Quantum has been cut in halfcan a leveraged ETF help bulls? - MSN

How the Strait of Hormuz ping pong ball is affecting commodity prices from soup to nuts - Barchart.com

Best Oil ETFs in Canada for 2026 - Stocktrades

Most Active Stocks Today: News, Charts, Live Quotes, Graphs - Coinbase

Stock List: Research Stocks from Around the World - GuruFocus

Fabry Disease Market Set for Robust Growth by 2034, Driven by Gene Therapy Breakthroughs and Expanding Pipeline from Sangamo, Sanofi, Amicus & Emerging Innovators | DelveInsight - Barchart.com

Non Tuberculous Mycobacterial Infections Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | Insmed, AN2 Therapeutics, Mannkind Corp., Spero Therapeutics, Savara Pharmaceuticals - Barchart.com

Exocrine Pancreatic Insufficiency Market: Expanding Revenue Landscape to 2034 – DelveInsight | First Wave BioPharma, Abbott Products, AAIPharma, Solvay Pharmaceuticals, Abbott, Forest Laboratories - Barchart.com

K2 Gold Receives Positive Record of Decision for Exploration Drilling at the Mojave Project, California - Barchart

Diabetes Market: Rapid Increment Driven by Innovation by 2032 – DelveInsight | Eli Lilly and Company, Regor Pharma AstraZeneca, Eccogene, Pfizer, Sciwind Biosciences USA Co., Ltd., MediciNova - Barchart.com

Stream if You Want to Go Faster: Netflix's New $120 Target - Barchart.com

Eosinophilic Esophagitis Market: Rapid Increment Driven by Innovation by 2034 – DelveInsight | Regeneron Pharma, Sanofi, Bristol-Myers Squibb, Ellodi Pharma, AstraZeneca, Allakos, EsoCap, Pfizer - Barchart

Systemic Sclerosis Market: Rapid Increment Driven by Innovation by 2034 – DelveInsight | Boehringer Ingelheim, Roche, Zenyaku Kogyo, Chugai Pharma, Kyowa Kirin, GSK, AstraZeneca, Amgen - Barchart.com

Multiple System Atrophy Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | Ionis Pharma, Biohaven Pharma, Lundbeck A/S, Alterity Therapeutics, Theravance Biopharma, Brain Neuro - Barchart

7 Best Leveraged ETFs for April 2026 - NerdWallet

Best Easter Products to Sell 2026: 9 Profitable Easter Crafts & Personalized Gift Ideas for Small Business - Barchart.com

UK gathers more than 40 countries to press Iran to reopen the Strait of Hormuz - Barchart.com

Conservatives call for lower gas tax and cuts to 'wasteful spending' to pay for it - Barchart

US-Europe rift widens as Trump lashes out at NATO allies over Mideast war - Barchart

Advocacy groups urge YouTube to protect kids from 'AI slop' videos - Barchart.com

Down 37% in 2026, Dan Ives Says You Should Buy the Dip in Zscaler Stock - Barchart.com

Energy Prices Could Soon ‘Skyrocket.’ Why Cheniere Is One of the Top-Rated Stocks to Buy Now. - Barchart

D-Wave Quantum Has Been Cut in Half—Can a Leveraged ETF Help Bulls? - MarketBeat

Cardi B and Steph Curry earn Webby Award nominations, along with Sydney Sweeney's bathwater - Barchart.com

Del Taco Celebrates National Burrito Day with Free Classic Burritos - Barchart

Is the Explosion of Single-Stock ETFs an Opportunity or a Danger? - MarketBeat

Arm Is Making ‘Bold Moves’ with New In-House Chips and Wall Street Loves It. Why Needham Says You Should Buy ARM Stock Here. - Barchart.com

ROYAL CARIBBEAN'S HERO OF THE SEAS INTRODUCES THE NEXT EVOLUTION OF FAMILY VACATION EXPERIENCES - Barchart.com

Judge won't block meeting that could exempt Gulf drilling from Endangered Species Act - Barchart

10 Inverse ETFs That Gain in a Bear Market - U.S. News Money

Asthma Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | GlaxoSmithKline, AB Science, Areteia Therapeutics, ARS Pharma, AstraZeneca, Pieris Pharma, Sanofi, Cumberland Pharma - Barchart.com

Stock Index Futures Rally as Oil Prices Tumble on U.S.-Iran Talks - Barchart.com

Muscle Invasive Bladder Cancer Market Set for Strong Growth Through 2034, Driven by Expanding Pipeline and Innovation | DelveInsight - Barchart

Sickle Cell Disease Market: Investment-Ready Growth Trends to 2034 – DelveInsight | BRL Medicine, Oryzon Genomics, GlaxoSmithKline, Agios Pharma, Beam Therapeutics Inc., Graphite Bio, Roche, Quercis - Barchart

The CLIF Brand Expands Energy Portfolio with New Energy Bites and Limited-Edition Chocolate Berry Energy Bar - Barchart.com

The Growing Risk in Private Credit: Why BlackRock and JPMorgan Are Raising Alarms - Barchart

Leverage Shares 2 X Long Grab Daily Etf (GRAG) 재무 분석

매출

순이익

현금흐름

주당 순 이익

GRAG과 유사한 종목